FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2332833045> ?p ?o ?g. }

• W2332833045 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DCBackground: A recent epidemiological study reported that triple-negative (TN) breast cancers occurred in association with obesity, which itself has been associated with increased risk for breast cancer. Obesity was present in 49.6% of patients with TN cancer but only in 35.8% of those with non-TN cancer. Considering the increasing epidemic of obesity this 13.8% increase is highly significant. Molecular effects of obesity on breast cancer growth and metastasis are mediated by dysregulation of adipocytokines, leptin and adiponectin. Our lab has previously shown that increased leptin signaling increases breast cancer metastasis whereas another adipocytokine, adiponectin inhibits metastatic potential of breast cancer cells. In the present study, we investigated the potential of thiazolidinediones (TZD) as adiponectin-mimetic in breast carcinogenesis and metastasis.Methods: TN breast carcinoma cell lines, MDA-MB-231 and MDA-MB-468, were used to study the effects on TZDs on TN breast cancer cell viability, anchorage-dependent tumor growth and anchorage-independent growth using the XTT colorimetric assay, clonigenecity assays, and soft-agar assays, respectively. Cell migration (wound-healing) assays were performed to assess the effects of TZDs on cell motility. Reverse-transcription polymerase chain reaction (RT-PCR) and immunoblotting were used to detect mRNA and protein expression levels in TZD treated cells, respectively.Results: Various Thiazolidinediones (TZD) have been developed including Rosiglitazone (RZG), Troglitazone (TGZ), and Pioglitazone (PZG). We found that rosiglitazone (RZG), a novel class of TZD increases adiponectin levels in TN breast cancer cells. We show that RGZ inhibits cell proliferation, anchorage-dependent and -independent growth of TN breast cancer cells in a dose-dependent manner. The ability of a cancer cell to migrate is an essential prerequisite for metastasis. Importantly, RZG treatment inhibits migration potential of TN breast cancer cells. Further examination of the underlying molecular mechanisms revealed that RGZ treatment increases phosphorylation of energy sensor AMP-activated protein kinase in TN breast cancer cells. Increased phosphorylation of AMPK increases its activity as evident by activation of its downstream target, ACC. Intriguingly, we discovered that RGZ treatment also decreases the activation of p-S6K indicating mTOR inhibition. Using AMPK-WT and AMPK-null fibroblasts, we further show that AMPK is required for RZG-mediated inhibition of metastatic potential of TN breast cancer cells.Conclusions: Our studies show that inhibition of metastatic properties of TN breast cancer cells by RGZ involves increased adiponectin levels, elevated AMPK (pAMPK) expression and activity. Our study suggests that RGZ can be used as a novel therapeutic agent for the treatment of aggressive, metastatic TN breast tumors that are unresponsive to current therapeutic regiments.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr LB-269." @default.
• W2332833045 created "2016-06-24" @default.
• W2332833045 creator A5006113857 @default.
• W2332833045 creator A5030200822 @default.
• W2332833045 creator A5031488790 @default.
• W2332833045 creator A5035543524 @default.
• W2332833045 creator A5059496981 @default.
• W2332833045 creator A5091245456 @default.
• W2332833045 date "2010-04-15" @default.
• W2332833045 modified "2023-09-27" @default.
• W2332833045 title "Abstract LB-269: Activation of energy sensor AMP-activated protein kinase by rosiglitazone: A novel means to rescue triple-negative breast cancer cells from metastasis" @default.
• W2332833045 doi "https://doi.org/10.1158/1538-7445.am10-lb-269" @default.
• W2332833045 hasPublicationYear "2010" @default.
• W2332833045 type Work @default.
• W2332833045 sameAs 2332833045 @default.
• W2332833045 citedByCount "0" @default.
• W2332833045 crossrefType "proceedings-article" @default.
• W2332833045 hasAuthorship W2332833045A5006113857 @default.
• W2332833045 hasAuthorship W2332833045A5030200822 @default.
• W2332833045 hasAuthorship W2332833045A5031488790 @default.
• W2332833045 hasAuthorship W2332833045A5035543524 @default.
• W2332833045 hasAuthorship W2332833045A5059496981 @default.
• W2332833045 hasAuthorship W2332833045A5091245456 @default.
• W2332833045 hasConcept C121608353 @default.
• W2332833045 hasConcept C126322002 @default.
• W2332833045 hasConcept C134018914 @default.
• W2332833045 hasConcept C143998085 @default.
• W2332833045 hasConcept C170493617 @default.
• W2332833045 hasConcept C194832188 @default.
• W2332833045 hasConcept C2776782570 @default.
• W2332833045 hasConcept C2777391703 @default.
• W2332833045 hasConcept C2779013556 @default.
• W2332833045 hasConcept C2780152017 @default.
• W2332833045 hasConcept C2780613262 @default.
• W2332833045 hasConcept C502942594 @default.
• W2332833045 hasConcept C511355011 @default.
• W2332833045 hasConcept C530470458 @default.
• W2332833045 hasConcept C71924100 @default.
• W2332833045 hasConceptScore W2332833045C121608353 @default.
• W2332833045 hasConceptScore W2332833045C126322002 @default.
• W2332833045 hasConceptScore W2332833045C134018914 @default.
• W2332833045 hasConceptScore W2332833045C143998085 @default.
• W2332833045 hasConceptScore W2332833045C170493617 @default.
• W2332833045 hasConceptScore W2332833045C194832188 @default.
• W2332833045 hasConceptScore W2332833045C2776782570 @default.
• W2332833045 hasConceptScore W2332833045C2777391703 @default.
• W2332833045 hasConceptScore W2332833045C2779013556 @default.
• W2332833045 hasConceptScore W2332833045C2780152017 @default.
• W2332833045 hasConceptScore W2332833045C2780613262 @default.
• W2332833045 hasConceptScore W2332833045C502942594 @default.
• W2332833045 hasConceptScore W2332833045C511355011 @default.
• W2332833045 hasConceptScore W2332833045C530470458 @default.
• W2332833045 hasConceptScore W2332833045C71924100 @default.
• W2332833045 hasLocation W23328330451 @default.
• W2332833045 hasOpenAccess W2332833045 @default.
• W2332833045 hasPrimaryLocation W23328330451 @default.
• W2332833045 hasRelatedWork W2001138013 @default.
• W2332833045 hasRelatedWork W2010089138 @default.
• W2332833045 hasRelatedWork W2027423872 @default.
• W2332833045 hasRelatedWork W2032011965 @default.
• W2332833045 hasRelatedWork W2038740066 @default.
• W2332833045 hasRelatedWork W2051147432 @default.
• W2332833045 hasRelatedWork W2088379844 @default.
• W2332833045 hasRelatedWork W2091140808 @default.
• W2332833045 hasRelatedWork W2317031066 @default.
• W2332833045 hasRelatedWork W2321416696 @default.
• W2332833045 hasRelatedWork W2334907202 @default.
• W2332833045 hasRelatedWork W2461562722 @default.
• W2332833045 hasRelatedWork W2610955440 @default.
• W2332833045 hasRelatedWork W2735209140 @default.
• W2332833045 hasRelatedWork W2740340845 @default.
• W2332833045 hasRelatedWork W2792509718 @default.
• W2332833045 hasRelatedWork W3001368618 @default.
• W2332833045 hasRelatedWork W3097421270 @default.
• W2332833045 hasRelatedWork W3169853327 @default.
• W2332833045 hasRelatedWork W570151595 @default.
• W2332833045 isParatext "false" @default.
• W2332833045 isRetracted "false" @default.
• W2332833045 magId "2332833045" @default.
• W2332833045 workType "article" @default.